New MRI technique may replace painful liver biopsies for hepatitis b patients

NCT ID NCT06779058

Recruiting now Diagnosis Sponsor: Shengjing Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether magnetic resonance elastography (MRE), a special type of MRI, can accurately measure liver scarring (fibrosis) in people with chronic hepatitis B. Researchers will compare MRE results to standard liver biopsies in 600 adults. If MRE works well, it could offer a safer, non-invasive way to monitor liver health over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Magnetic resonance elastography (MRE) imaging
What this could lead to: If successful, MRE could become a reliable, non-invasive way to monitor liver fibrosis, reducing the need for painful liver biopsies.
What could go wrong: This is an observational study, not a treatment trial. MRE accuracy may vary, and it is not yet proven to replace biopsy in all cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic hepatitis B virus infection cirrhosis of liver fibrotic liver disease hepatitis B virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC HEPATITIS B LIVER FIBROSIS

Contacts and locations

Locations

Shengjing Hospital
RECRUITING

Shenyang, Liaoning, 210000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.